Histamine H3 Receptor Ligands
    52.
    发明申请
    Histamine H3 Receptor Ligands 审中-公开
    组胺H3受体配体

    公开(公告)号:US20110009420A1

    公开(公告)日:2011-01-13

    申请号:US12883852

    申请日:2010-09-16

    摘要: The present invention provides compounds of the formula wherein R1, R2 and B are as herein described, pharmaceutical compositions comprising these compounds, use of these compounds for the preparation of pharmaceutical compositions and methods of use thereof for the treatment and/or prevention of disorders and diseases wherein modulation of the H3 receptor is beneficial.

    摘要翻译: 本发明提供下式的化合物,其中R1,R2和B如本文所述,包含这些化合物的药物组合物,这些化合物用于制备药物组合物的用途及其用于治疗和/或预防疾病的方法,以及 其中H3受体的调节是有益的疾病。

    Substituted homopiperidine, piperidine or pyrrolidine derivatives
    55.
    发明授权
    Substituted homopiperidine, piperidine or pyrrolidine derivatives 失效
    取代的高哌啶,哌啶或吡咯烷衍生物

    公开(公告)号:US07799924B2

    公开(公告)日:2010-09-21

    申请号:US11962455

    申请日:2007-12-21

    IPC分类号: C07D401/00 A61K31/445

    摘要: A novel class of substituted homopiperidine, piperidine and pyrrolidine derivatives, methods for their preparation, pharmaceutical compositions comprising them and use thereof in the treatment of disorders related to the histamine H3 receptor. More particularly, the compounds possess histamine H3 receptor antagonistic activity and are thus useful in the treatment of disorders in which a histamine H3 receptor blockade is beneficial.

    摘要翻译: 一类新的取代的高哌啶,哌啶和吡咯烷衍生物,其制备方法,包含它们的药物组合物及其用于治疗与组胺H3受体有关的病症的用途。 更具体地,化合物具有组胺H3受体拮抗活性,因此可用于治疗组胺H3受体阻断有益的病症。

    Substituted homopiperidine, piperidine or pyrrolidine derivatives
    59.
    发明授权
    Substituted homopiperidine, piperidine or pyrrolidine derivatives 失效
    取代的高哌啶,哌啶或吡咯烷衍生物

    公开(公告)号:US07332508B2

    公开(公告)日:2008-02-19

    申请号:US10735963

    申请日:2003-12-15

    IPC分类号: A61K31/454 C07D43/02

    摘要: A novel class of substituted homopiperidine, piperidine and pyrrolidine derivatives, methods for their preparation, pharmaceutical compositions comprising them and use thereof in the treatment of disorders related to the histamine H3 receptor. More particularly, the compounds possess histamine H3 receptor antagonistic activity and are thus useful in the treatment of disorders in which a histamine H3 receptor blockade is beneficial.

    摘要翻译: 一类新的取代的高哌啶,哌啶和吡咯烷衍生物,其制备方法,包含它们的药物组合物及其用于治疗与组胺H3受体有关的病症的用途。 更具体地,化合物具有组胺H3受体拮抗活性,因此可用于治疗组胺H3受体阻断有益的病症。